Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instituto Atlas Biosocial is a Brazilian non-profit organization dedicated to supporting patients and families affected by rare diseases, with a specialized focus on Neuronal Ceroid Lipofuscinosis (CLN), commonly known as Batten Disease. The institute serves as a critical bridge between patients, healthcare providers, and the scientific community to accelerate diagnosis and improve access to specialized treatments. Its core activities include providing psychological support, legal guidance for accessing healthcare rights, and social assistance to vulnerable families. Beyond direct patient care, Atlas Biosocial is actively involved in public policy advocacy and the promotion of scientific research through data collection and registries. The organization collaborates with international rare disease networks to bring global best practices to the Brazilian healthcare landscape. By raising public awareness and educating medical professionals, the institute strives to reduce the diagnostic odyssey often faced by those with rare genetic conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instituto Atlas Biosocial.